Conclave 2025, Vikrant Shrotriya, Managing Director of Novo Nordisk India, said that a weight loss drug is not a magic pill.

As the global demand for obesity treatments skyrockets, Vikrant Shrotriya discusses the complex nature of obesity, the ...

Vikrant Shrotriya, Novo Nordisk India's Managing Director, addressed concerns over the side-effects of Ozempic. He said that the weight-loss drug has been through a thorough evaluation process.

Exclusive: Vikrant Shrotriya, Corporate Vice President & Managing Director, Novo Nordisk India, has warned that the 'wonder drug' Ozemic is not a 'party drug'. In a special conversation with Kalli ...

Aligning with Prime Minister Narendra Modi’s clarion call to combat obesity, Novo Nordisk Education Foundation (NNEF) and ...

The initiatives to improve healthcare access — including Ayushman Bharat, which provides financial protection and better ...

Ozempic is not a magic pill, Vikrant Shrotriya, Managing Director, India division of the weight-loss drug-maker said while speaking at a discussion on obesity at the India Today Conclave 2025. “When ...

Corporate Vice President and Managing Director at Novo Nordisk India ...